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Abstract
We generated cortical interneurons (cINs) from iPSCs derived from14 healthy controls (HC cINs) 
and 14 patients with schizophrenia (SCZ cINs). Both HC cINs and SCZ cINs were authentic, fired 
spontaneously, received functional excitatory inputs from host neurons, and induced GABA-
mediated inhibition in host neurons in vivo. However, SCZ cINs had dysregulated expression of 
protocadherin genes, which lie within documented SCZ loci. Mice lacking protocadherin α 
showed defective arborization and synaptic density of prefrontal cortex cINs and behavioral 
abnormalities. SCZ cINs similarly showed defects in synaptic density and arborization, which 
were reversed by inhibitors of Protein Kinase C, a downstream kinase in the protocadherin 
pathway. These findings reveal an intrinsic abnormality in SCZ cINs in the absence of any circuit-
driven pathology. They also demonstrate the utility of homogenous and functional populations of a 
relevant neuronal subtype for probing pathogenesis mechanisms during development.
Keywords
Schizophrenia; induced pluripotent stem cells; interneurons; protocadherin
Introduction
Schizophrenia (SCZ) is a devastating disease affecting 1% of the adult population 
worldwide. It is a highly heritable 1 neurodevelopmental disorder 2, characterized by 
positive symptoms (e.g., hallucinations and delusions), negative symptoms (e.g., apathy, 
anhedonia) and cognitive symptoms (e.g., impairments of memory, executive functions and 
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attention) 3. Cognitive and negative symptoms persist even with antipsychotic treatment 4, 
preventing normal functioning of patients. Given the fact that SCZ remains the seventh most 
costly medical disorder in our society, it is imperative to unravel its pathogenic mechanisms 
to develop novel and efficacious treatments.
So far, a large genome wide association study (GWAS) of SCZ has convincingly identified 
108 risk loci with genome-wide significance 5, opening the way to a deeper understanding of 
SCZ pathogenic mechanisms. However, deciphering how these risk loci affect gene 
expression and result in SCZ pathogenesis is not a trivial task. Recent studies are making 
progress in this regard and have shown correlations between risk locus genotypes and gene 
expression levels (e.g. FURIN and C4A) 6,7. However, whether the observed manner of gene 
expression changes cause SCZ-relevant neuro-anatomic and behavioral deficits in animal 
models needs to be determined. One caveat in current expression quantitative trait loci 
(eQTL) studies is that most of the attempts to connect gene expression levels with risk loci 
are based on transcriptome studies carried out on postmortem tissues 6, which typically 
involve subjects with chronic illness and years of exposure to psychotropic medications. 
Such studies cannot address pathogenic mechanisms operational during development 2. 
Thus, disease-specific developmental brain tissue will be needed to unravel the role of these 
risk genes during the critical developmental periods. Induced pluripotent stem cell (iPSC) 
technology 8 allows us to generate such patient-specific developmental brain tissues with the 
same genetic make-up as the patient brains.
SCZ modeling using iPSCs has begun 9, and there has been a steady stream of studies 
reporting SCZ-specific transcriptome aberrations and cellular phenotypes in iPSC-derived 
neural tissues 10. It will be important to sort out causal abnormalities vs. changes in effectors 
downstream of causal abnormalities. Correlation with genetic risk loci will provide a 
pathway for identifying causal abnormalities. In addition, animal model studies can help 
determine causal abnormalities that can recapitulate SCZ-like histological and behavioral 
abnormalities. One note of caution in using iPSC-derived neural tissues for studying SCZ 
pathology is the heterogeneity and stochasticity of iPSC-derived tissues, which can result in 
inconsistency due to the changing composition of neuronal subtypes within culture. Single 
cell RNA-seq can be used to address this problem. However, due to the more limited 
sequencing depth inherent to single cell RNA-seq, it is not as easy to identify differences in 
low abundance genes, which could play critical roles. Thus, generation of a homogeneous 
and consistent population of neural subtypes is critical for successful disease modeling using 
iPSCs.
Cortical GABAergic interneurons (cINs) are one of the most consistently affected neuronal 
types in SCZ, especially medial ganglionic eminence (MGE)-derived parvalbumin (PV)+ or 
somatostatin (SST)+ expressing cINs, as shown in numerous post-mortem studies 11,12. In 
line with these findings, a role for altered GABA neurotransmission in SCZ was suggested 
to disrupt cortical gamma oscillations and thus cause cognitive deficits in patients 13. 
Accordingly, GABAA receptor agonists were shown to restore gamma band activity in SCZ 
patients, accompanied by some degree of improved cognitive functions 14. Furthermore, 
developmental cIN hypofunction resulted in a SCZ-like phenotype, including deficits in 
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dopaminergic systems in adult mice 15, suggesting a role of impaired cIN development in 
SCZ pathogenesis.
In this study, we used homogeneous populations of cINs derived from iPSCs to analyze cIN-
intrinsic deficits in SCZ and found that the protocadherin pathway is significantly altered in 
SCZ cINs early in development. cINs in the prefrontal cortex (PFC) of Pcdha knockout 
(KO) mice showed arborization and synaptic deficits. In line with this, knock down (KD) of 
protocadherins in healthy control (HC) cINs resulted in significant reduction in arborization. 
Developmental SCZ cINs displayed arborization deficit in cell culture and synaptic deficits 
in vivo following transplantation into mouse brains. These deficits were also observed in 
cINs in SCZ postmortem PFCs. Inhibitors of protein kinase C (PKC), a downstream kinase 
in the protocadherin signaling pathway, normalized the arborization deficits observed in 
SCZ cINs. This study has revealed intrinsic deficits in SCZ cINs in the absence of any 
circuit-mediated deficits and demonstrates the utility of iPSC-derived homogeneous neural 
subtypes to illuminate the mechanistic basis of SCZ pathogenesis and to identify potential 
novel therapeutic targets.
Results
Homogeneous populations of cINs were generated from HC and SCZ iPSCs
As the first step to study the SCZ pathogenic mechanisms in disease-relevant developmental 
tissues, we generated iPSCs from HC and SCZ fibroblasts using footprint-free modified 
RNA methods 16. Footprint-free reprogramming is even more important for studying SCZ 
where multiple single nucleotide polymorphisms (SNPs) with small effects work together to 
result in pathogenesis. We chose Caucasian male patients to reduce variation caused by 
ethnicity and gender. Further, we chose patients who required clozapine treatment to narrow 
down the patient group to those with more severe cases of the disease (Figure 1a). iPSCs 
reprogrammed with modified RNA transfection 16 showed human pluripotent stem cell 
(hPSC)-like morphology and expressed hPSC markers (Figure 1b).
To obtain a homogeneous population of developmental cINs from generated iPSCs, we 
differentiated them using the protocol we optimized previously 17 with a slight modification 
(Figure 1c). This protocol generated a homogeneous population of developmental cINs from 
multiple iPSC lines. The homogeneity was extensively analyzed by expression of the 
neuronal marker, β-tubulin III, MGE-derived cIN marker SOX6 18, and GABA-synthesizing 
enzyme glutamate decarboxylase 1 (GAD1) (Figure 1d-e and Supplementary Fig. 1). CGE-
derived cINs or non-cIN neural subtypes were only rarely observed regardless of their 
disease status (Supplementary Fig. 2). We further analyzed the phenotypes of the generated 
cINs by quantitative real time polymerase chain reaction (PCR) analysis, comparing them 
with undifferentiated iPSCs and induced glutamatergic neurons 19. We observed that cIN-
specific genes (GAD1, LHX6, NKX2–1 and SOX6) are highly expressed in cIN groups but 
not in the other cell groups. On the other hand, there was minimal expression of non-cIN 
markers (NANOG, PAX6, TBR1 and SLC17A7 (Vglut1)) in generated cINs (Figure 1f), 
confirming the identity and homogeneity of the generated cells. The homogeneity of 
differentiated progeny is critical for the reliable transcriptome analysis of developing cINs.
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Neuronal and synaptic properties of cINs transplanted into mouse cerebral cortex
Previous studies on cIN induction from human PSCs focused on human embryonic stem 
cell-derived cINs, and thus it was unclear whether cINs derived from iPSCs, which went 
through the reprogramming process from skin cells, are authentic and functional, and thus 
suitable for disease modeling. To address this, we performed extensive electrophysiological 
analysis after grafting these cells into mouse brains. HC and SCZ cINs were transduced with 
lentivirus expressing channelrhodopsin 2 (ChR2) (H134R)-green fluorescence protein (GFP) 
fusion protein under the control of the synapsin promoter (LV-Syn-ChR2 (H134R)-GFP) to 
permit optogenetic study as well as the identification of grafted cells in brain slices. They 
were then transplanted into the cerebral cortices of Nod Scid mice, followed by 
electrophysiological analysis 7 months after transplantation (Figure 2a). In GFP+ grafted 
cells, blue light illumination induced typical ChR2-mediated currents (Figure 2b) and 
evoked action potential (AP) firings (Supplementary Fig. 3a). The passive membrane 
properties of SCZ cINs, including membrane resistance (Rm) and membrane capacitance 
(Cm), were similar to those in the HC group (Supplementary Fig. 3b–c). When depolarizing 
voltage pulses were applied, grafted cINs showed rapidly desensitizing inward currents and 
sustained outward currents (Figure 2c), indicating the expression of voltage-gated Na+ 
channels and K+ channels. There was no difference between groups in the voltage-dependent 
Na+ current density (Supplementary Fig. 3d) and the K+ current density (Supplementary Fig. 
3e).
In current-clamp mode, the injection of depolarizing currents induced AP firings in all 
human cINs examined (Figure 2d). Non-accommodating repetitive AP firings were observed 
in >75% of the grafted cINs in both groups, whereas grafted cells in the remaining 
proportion displayed single or burst AP firing patterns. The frequency of AP firings induced 
by current injection was comparable between groups (Figure 2e) with no significant 
difference in afterhyperpolarization (AHP), AP threshold and AP half-width (Supplementary 
Fig. 3f–h). However, the resting membrane potential (RMP) of the cINs was significantly 
more depolarized in the SCZ group than in the HC group (Supplementary Fig. 3i). At RMP, 
spontaneous AP (sAP) firings were observed in >80% of human cINs in both groups (Figure 
2f and Supplementary Fig. 3j), with comparable sAP frequency between groups 
(Supplementary Fig. 3k), suggesting that most grafted cINs generate tonic spontaneous 
firings in both the SCZ and HC groups. Neuronal properties of iPSC-derived cINs were also 
confirmed in vitro (Supplementary Fig. 4). These results demonstrate that HC and SCZ cINs 
develop into functional cINs whose neuronal properties are similar to those of endogenous 
interneurons.
We next analyzed the synaptic properties of grafted human cINs to determine whether they 
integrate into adult brain circuitry and receive excitatory synaptic inputs from host cortical 
neurons. In acute cortical slices, all 26 GFP+ grafted interneurons showed spontaneous 
excitatory postsynaptic currents (sEPSCs) at –85 mV in voltage-clamp mode (Figure 2g). 
These currents were inhibited completely by NBQX, a glutamate receptor antagonist, in all 3 
grafted cells examined, indicating that they were mediated by the excitatory 
neurotransmitter, glutamate. There was no significant difference in the frequency or 
amplitude of sEPSCs between the HC and SCZ groups (Supplementary Fig. 5a–c). These 
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results suggest that human cINs from both HC and SCZ groups have functional postsynaptic 
machinery to receive excitatory synaptic inputs from host glutamatergic cortical neurons.
We also examined whether grafted human cINs had presynaptic mechanisms for the release 
of GABA, which induces inhibitory postsynaptic responses in host cortical neurons. To this 
end, we used optogenetic approaches to selectively stimulate grafted cINs expressing ChR2-
GFP and record postsynaptic responses in GFP– host cortical neurons (Figure 2h-i). Short 
pulses of blue light illumination induced postsynaptic currents at 0 mV in voltage-clamp 
mode, which were inhibited completely by SR95531, a GABAA receptor antagonist (Figure 
2j), indicating that they were mediated by inhibitory neurotransmitter GABA. Proportions of 
host neurons with IPSCs were comparable between groups (Figure 2k-l), suggesting the 
majority of recorded host neurons received inhibitory inputs from grafted cINs. Moreover, 
the peak amplitude of inhibitory postsynaptic currents (IPSCs) induced by photostimulation 
was not significantly different between groups (Figure 2k-l and Supplementary Fig. 5d). Our 
power analysis indicates that we would need to record from 196 host neurons to achieve 
80% power for detecting a 36.5 pA mean difference with standard deviation = 57.2 pA and 
intra-cluster correlation = 0.2, pointing to the large sample size needed to detect mild 
phenotypes of SCZ. These results demonstrate that grafted cINs have presynaptic machinery 
for GABA release and inhibit host cortical neurons.
PCDHA2 expression is altered in SCZ cINs
Given the evidence that iPSC-derived HC and SCZ cINs are authentic and fully functional 
interneurons, we then asked whether there were any SCZ cIN-specific abnormalities in gene 
expression during development. We performed RNA-seq analysis, comparing transcriptomes 
of HC cINs to SCZ cINs after 8 weeks’ differentiation. A total of 273 million reads were 
obtained from 8 lines (4 HC and 4 SCZ) with three independent differentiations 
(Supplementary Fig. 6a). The total number of genes were similar among different RNA-seq 
reactions (Supplementary Fig. 6b), suggesting that the read depth from each RNA-seq was 
sufficient to identify most of the genes expressed. When we performed a pair-wise 
comparison, the average r2 value for biological replicates was about 0.95, showing high 
correlation that reflects the homogeneous and efficient cIN generation from iPSCs 
(Supplementary Fig. 6c). Along the same line, the average r2 between individuals in this 
study was about 0.93, as compared to about 0.82 for postmortem tissues (Supplementary 
Fig. 6c), stressing the consistency of iPSC-derived cIN samples. Principal component 
analysis showed that biological replicates from the same individual tend to cluster together 
(Supplementary Fig. 6d), whereas there is no clear separation based on diagnostic group, 
indicating the subtle nature of SCZ phenotype (Supplementary Fig. 6d–e). Neuronal markers 
(MAP2 and DCX) and cIN markers (GAD1, VGAT, SST and Lhx6) were highly expressed, 
whereas the expression of non-relevant markers such as GFAP (astrocyte marker), MBP 
(oligodendrocyte marker), Vglut2 (glutamatergic neuron marker), CoupTFII (CGE-derived 
cIN marker), Olig2 (early MGE progenitor marker), ChAT (cholinergic neuron marker), TH 
(dopaminergic neuron marker) and TPH2 (serotonergic neuron marker) were low (Figure 3a 
and Supplementary Fig. 7a). Notably, expression of those markers did not differ between HC 
and SCZ (Figure 3a). While the global gene expression pattern did not show clear separation 
between HC and SCZ, select genes did exhibit significant differences in expression between 
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SCZ and HC, such as PCDHA2 (Figure 3b and Supplementary Fig. 6f), which was 
confirmed by real time PCR analysis (Figure 3c).
To test whether alteration in PCDHA2 expression is also observed in other neuronal 
subtypes, we generated glutamatergic neurons using the Ngn2 induction protocol 19 with a 
slight modification (Figure 3d). Glutamatergic neurons could be efficiently generated from 
both HC and SCZ iPSCs (Figure 3e). Real time PCR analysis showed no significant change 
in PCDHA2 expression in SCZ glutamatergic neurons (Figure 3f). Further studies will 
reveal whether this observation is universal for all developmental glutamatergic neurons 
rather than just induced glutamatergic neurons analyzed here.
Downregulation of multiple protocadherin family members in SCZ cINs
Considering the heterogeneity of SCZ etiology, we expanded the sample size and performed 
RNA-seq analysis on a larger cohort with 14 HC lines and 14 SCZ lines after 8 weeks’ 
differentiation (Figure 4a). Again, the same patient selection criteria was employed with 
Caucasian Males who required Clozapine treatment. In addition to PCDHA2, there are 
additional PCDHA genes that are down regulated in SCZ cINs, including PCDHA3, 6 and 8 
(Figure 4b). Real time PCR analysis confirmed significant decreases of these PCDHA 
family members in SCZ cINs (Figure 4c), whereas expression of PCDHA3, 6 and 8, like 
PCDHA2, was not altered in SCZ glutamatergic neurons (Supplementary Fig. 8a).
Publicly available eQTL databases (https://www.gtexportal.org, https://www.synpase.org/
cmc) showed that there are numerous PCDHA2 eQTL SNPs with high SCZ association 
(Supplementary Fig. 8b), suggesting a potential role of SCZ risk loci in regulating 
expression of PCDHA2. We selected rs7445192 for genotype-gene expression correlation 
analysis due to its high correlation with SCZ with a higher odd ratio and significant eQTL 
status for PCDHA2 (Supplementary Fig. 8c). There was a trend of decreasing PCDHA2 
expression in iPSC-derived cINs with more alternate alleles (A) of rs7445192 (Figure 4d), 
though this did not reach statistical significance. Power analysis showed that 256 samples 
would be needed to reach statistical significance. Searches in the CommonMind portal 
showed that PCDHA2 has 533 eQTL SNPs and PCDHA3 has 0 eQTL SNPs. PCDHA6 has 
88 eQTL SNPs, but rs7445192 was not one of them (Supplementary Fig. 8d). Interestingly, 
we did not see genotype-expression level correlation in these two genes without a previous 
eQTL connection with this SNP (Figure 4d). PCDHA8 has 800 eQTL SNPs, including 
rs7445192, and also shows the tendency of decreasing expression by more alternate alleles 
(Figure 4d), though again this finding did not reach statistical significance. Power analysis 
showed that 226 samples would be needed to reach statistical significance.
In addition to PCDHA members, the majority of other protocadherin members were also 
downregulated in SCZ cINs (Figure 4e). Real time PCR analysis confirmed significant 
decreases of all PCDHA and PCDHG family members in SCZ cINs, using primers against 
the PCDHA-constant region (CR) and PCDHG-CR (Supplementary Fig. 8e). However, 
expression of these genes was not altered in SCZ glutamatergic neurons (Supplementary 
Fig. 8f). The publicly available eQTL databases showed that other highly affected 
protocadherins also had eQTL within the SCZ risk loci (Chr5:140,023,664–140,222,664) a 
little bit further from the area where most of their eQTL reside (Figure 4f and 
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Supplementary Fig. 8g). This suggests that this SCZ risk locus may be related to the 
regulation of multiple protocadherin family members in addition to PCDHA members.
Altered PFC cIN development and impaired prepulse inhibition in Pcdha KO mice
Having observed downregulation of multiple protocadherin family members, including 
PCGHA and PCDHG, in SCZ cINs, we examined the effect of protocadherin hypofunction 
on cIN development using a mouse model with a Pcdha null mutation (Δα/Δα) 20, where all 
members of the Pcdha family are knocked out. Pcdhg is necessary for proper Pcdha 
localization and function 20,21 (but not the other way around). As such, Pcdhg KO mice 
show severe lethal phenotypes, unlike Pcdha KO mice, which show mild phenotypes. Thus, 
we used the partially compromised protocadherin function in Pcdha KO mice to model the 
protocadherin hypofunction seen in SCZ cINs. We analyzed the arborization of PFC cINs 
within 150 µm from the cell bodies and found a mild but significant arborization deficit in 
Pcdha KO cINs, shown by significant decreases in neurite number from soma, total branch 
number, and total neurite length (Figure 5a and Supplementary Fig. 9a). We also observed 
deficits in inhibitory synapse formation of PFC cINs in Pcdha KO mice by analyzing the 
number of VGAT+ puncta on PV+ cINs that were juxtaposed to Gephyrin+ puncta (Figure 5b 
and Supplementary Fig. 9b). However, there was no significant difference in the excitatory 
synapses that cINs receive between Pcdha KO mice and littermate wild type controls (Figure 
5c and Supplementary Fig. 9c). These results suggest the importance of the protocadherin 
pathways in the normal development of cINs in the PFC.
Previous studies have shown that Pcdha KO mice harbor projection and connection deficits 
in different brain regions and display deficits in contextual learning and working memory 21, 
which are relevant to the SCZ clinical phenotype. We tested whether Pcdha KO mice show 
deficits in prepulse inhibition (PPI), which occur in many SCZ patients and can be 
attenuated by antipsychotic treatment 22. Pcdha CR KO mice 23, which have non-functional 
Pcdha expression, showed significant deficits in PPI compared to their wild type littermates 
(Figure 5d). In addition, Pcdha hypomorphic mice (ΔBneo/ΔBneo) 24 also showed 
significant PPI deficits (Figure 5e), suggesting the importance of the protocadherin pathway 
for normal sensorimotor gating.
Deficits in arborization and synaptic density in SCZ cINs
Having observed cIN deficits by protocadherin hypofunction during cIN development, we 
tested whether SCZ cINs also demonstrate similar phenotypic deficits. To analyze 
arborization, we infected HC and SCZ cINs with a limiting titer of lentivirus expressing 
GFP under the Ubiquitin promoter (LV-Ubi-GFP) to label cells only scarcely. We then traced 
and analyzed GFP+ cells. There was a mild but significant decrease in neurite number from 
the soma, total branch numbers, and total neurite lengths in SCZ cINs compared to HC cINs 
(Figure 6a). Linear regression analysis showed that the expression level of PCDHA2, 
PCDHA3, PCDHA6 and PCDHA8 has weak or mild correlation with arborization 
(Supplementary Fig. 10a). It was shown that in the excitatory glutamatergic neuronal 
context, protocadherin CR inhibits focal adhesion kinase (FAK) and in turn, PKC 25, which 
otherwise inhibits arborization by inactivating MARCKS via phosphorylation 21,25. Thus, 
we tested whether treating SCZ cINs with PKC inhibitors can reverse this deficit by 
Shao et al. Page 8
Nat Neurosci. Author manuscript; available in PMC 2019 July 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
protocadherin hypofunction. Treatment with the PKC inhibitor GO6893 reversed the 
arborization deficit in the SCZ cINs, whereas it did not produce a significant difference in 
HC cINs (Figure 6b and Supplementary Fig. 10b). To more directly test the effect of lower 
protocadherin expression on cINs, we performed gene KD experiments against the PCDHA-
CR or the PCDHG-CR that knock down entire PCDHA or PCDHG families (Supplementary 
Fig. 10c). One-month old cINs were transfected with negative control siRNA, PCDHA 
siRNA, PCDHG siRNA or PCDHA siRNA+PCDHG siRNA, infected with limiting titer of 
LV-Ubi-GFP virus, and traced at 7 days after transfection. There was a mild but significant 
decrease in arborization of HC cINs by PCDHA KD or PCDHG KD and to a lesser degree 
in SCZ cINs (Figure 6c and Supplementary Fig. 10d).
To study HC and SCZ cINs in an in vivo circuit environment, we transplanted 8 weeks-old 
cINs to the cerebral cortices of Nod Scid mice after labeling them with LV-Syn-ChR2 
(H134R)-GFP and analyzed their phenotypes (Figure 7a). One of the characteristic 
behaviors of developing cINs is robust migration even in transplanted adult brains, 
comparable to their extensive migration during early development 26. iDISCO+ clearing 27 
and Light sheet microscopy showed robust migration of grafted cINs (Figure 7b), up to 
2,000 µm from the injection site in the adult mouse cortex (Figure 7c-d). We further 
characterized cINs in the brain environment by immunocytochemistry. Consistent with their 
MGE-derived phenotype, many grafted cINs express either MEF2C, a marker enriched in 
PV+ interneuron precursors in mice 28, or SST (Figure 7e), regardless of their disease status. 
We also observed that small proportion of cINs started to express PV, regardless of their 
disease status (Supplementary. Fig. 11a). Overall these results suggest that there was no 
difference in cIN fate determination between HC and SCZ populations. Synapse analysis 
showed a mild but significant deficit in inhibitory synapse formation by SCZ cINs compared 
to HC cINs (Figure 7f and Supplementary Fig. 11b). The excitatory synapse density did not 
differ between grafted HC cINs and SCZ cINs (Figure 7g and Supplementary Fig. 11c). 
Linear regression analysis showed that expression level of PCDHA2, PCDHA3, PCDHA6 
and PCDHA8 has weak or mild correlation with inhibitory synapse formation 
(Supplementary Fig. 11d). These results suggest that SCZ cINs have an intrinsic deficit in 
the formation of inhibitory synapses in the absence of a SCZ circuit environment.
Synaptic and arborization deficits in cINs in postmortem brains from SCZ patients
Having observed developmental SCZ cIN-intrinsic phenotypic deficits, we sought to explore 
whether the observed developmental deficits continue to be present in adult post mortem 
brains. Thus, we analyzed layer 3 PV+ cINs from 8 HC vs. 8 SCZ postmortem PFCs (Figure 
8a). Arborization analysis showed a mild but significant deficit in SCZ postmortem cINs, 
shown by significant decreases in neurite number from soma, total branch number, and total 
neurite length (Figure 8b and Supplementary Fig. 12a). This was consistent with the 
phenotypes observed in developmental cINs. A mild but significant deficit in inhibitory 
synapse formation was observed also in postmortem SCZ cINs in the PFC (Figure 8c and 
Supplementary Fig. 12b), again consistent with results from developmental cINs. However, 
unlike in the developmental SCZ cINs, excitatory synapse formation was significantly 
reduced in postmortem SCZ cINs (Figure 8d and Supplementary Fig. 12c), possibly due to 
deficits in glutamatergic neurons.
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Discussion
In this study, we have found that the expression of protocadherins, genes within well-
documented SCZ risk loci 5, are significantly downregulated in SCZ cINs during 
development and that their altered expression resulted in disease-relevant phenotypes in KO 
mice and human SCZ cINs. The discovery of altered expression of genes within SCZ risk 
loci is important as it may shed light on the causal pathophysiology of SCZ. The presence of 
numerous significant eQTL SNPs for PCDHA members within SCZ risk loci suggests that 
this particular SCZ risk locus may regulate PCDHA gene expression. The modest change of 
PCDHA gene expression we observed is in agreement with the previous large scale eQTL 
studies for SCZ risk loci 6. Also, it is consistent with the notion that small changes in many 
genes may epistatically cause the disease phenotype, stressing the importance of studying 
“pathway” changes instead of “single gene” changes to better understand SCZ pathogenesis. 
Interestingly, the direction of expression alterations by risk alleles are different depending on 
the brain regions examined, stressing the importance of using disease-relevant and 
homogeneous cell populations to understand the effect of the risk genotype.
Protocadherins are a family of cell surface proteins that play important roles during brain 
development 21. They are transferred between the cell surface and intracellular organelles 
29,30
 and cell surface localization of PCDHA was shown to be facilitated by forming a 
heterodimer with PCDHG 31,32. Once on the cell surface, PCDHA, often times as a 
heterodimer with PCDHG, inhibits the FAK-PKC pathway that inhibits neurite arborization, 
thereby facilitating neuronal arborization 25,33. PCDHA is robustly expressed during late 
embryonic to early postnatal period in axons, then, expression deceases with myelination 
34,35
, suggesting its role in axonal path finding and arborization. In this study, we observed 
that Pcdha deficiency results in an arborization defect in cINs in Pcdha KO mouse PFC as 
well as in SCZ cINs in vitro, which was reversed by inhibiting PKC, downstream in the 
protocadherin pathway. In addition to their role in arborization, PCDHA and PCDHG 
proteins are localized to synapses during development 29,30,36, but not in many mature 
neurons 21, suggesting their role during synaptogenesis. Consistent with this inference, we 
observed an inhibitory presynaptic deficit in cINs both in the Pcdha null mice PFC as well as 
in SCZ cINs transplanted into mouse cortex. Downregulation only in PCDHA members is 
not likely to generate protocadherin-related phenotypes in SCZ cINs, considering the mild 
phenotype observed in Pcdha KO mice, unlike the severe lethal phenotypes of Pcdhg KO 
mice 37. However, down-regulation of many members of the protocadherin family, including 
both PCDHA and PCDHG, may explain the observed mild phenotype in SCZ cINs. Modest 
abnormal phenotype in SCZ cINs is in line with the overall mild pathology of SCZ observed 
in postmortem studies.
SCZ is a uniquely human disease, not easy to model behaviorally in animals, but there are 
animal models where environmental and genetic risk factors generate SCZ-like behaviors 38. 
SCZ patients display sensory motor gating deficits, cognitive deficits and anhedonia, and 
these deficits can be seen in animal models of SCZ. Previously, it was reported that Pcdha 
null mutant mice have a working memory deficits 21,24. In addition, in this study, we 
observed Pcdha null mutant mice and Pcdha hypomorphic mice display deficits in PPI, 
indicating that reduced Pcdha expression results in impaired sensory motor gating. This 
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behavioral deficit is consistent with SCZ-like histological deficits that we observed in PFC 
cINs in Pcdha null mice and suggests the role of reduced PCDHA expression in SCZ 
pathogenesis.
Previously, it was not clear whether cIN hypofunction in SCZ PFC was due to intrinsic 
defects in cINs and/or as a result of hypofunction of glutamatergic input into cINs. In this 
study, using homogeneous population of cINs without presence of any SCZ glutamatergic 
input, we could observe cIN-intrinsic abnormalities in vitro and in vivo. These findings 
demonstrate the potential of homogeneous iPSC-derived neural subtypes for unraveling 
disease mechanisms. In this example, the mixed cell populations used in most previous iPSC 
disease modeling studies 10 would not have allowed detection of cell type-specific 
pathological changes of minor populations. We also obtained a homogeneous population of 
glutamatergic neurons using Ngn2-based induction, a well-accepted protocol in the field 39, 
though there is a caveat that the induced glutamatergic neurons may not be identical to in 
vivo glutamatergic neurons. In addition to the homogeneity and consistency of generated 
cINs, the opportunity to perform extensive electrophysiological characterization gave us 
confidence about their authenticity and functionality. In this study, IPSCs in host cortical 
neurons induced by stimulation of grafted cINs were not significantly different between 
groups, although significant differences were detected in synapse analysis. This could be due 
to small sample size of our electrophysiological experiments and/or compensatory 
mechanisms 40 in human cINs transplanted into normal mice brains. In the future, further 
technical developments that allow high throughput analysis, such as the Patch Clamp array, 
will be pivotal to obtaining enough power to electrophysiologically study mild SCZ 
phenotypes. iPSC-derived human disease tissues provide a method to screen chemicals to 
correct identified cellular phenotypes, thus providing unprecedented opportunities to develop 
mechanistic treatments. This is especially important, considering the fact that the complex 
genetics of SCZ, with over a hundred risk alleles already identified, each having only a 
modest effect, are difficult to replicate in experimental animals. Not surprisingly, many 
effective treatments developed in animal models have failed in human clinical trials 41,42. In 
our study, we have observed that treatment with a PKC inhibitor corrects the abnormal 
cellular phenotype in SCZ cINs. In this regard, it is interesting to note that a PKC inhibitor 
was successfully used to treat acute mania in bipolar disorders in small scale clinical trials 
43–45
, as bipolar disorder shows substantial clinical and genetic overlap with SCZ 46.
Reduction in synapse density in both excitatory synapses and inhibitory synapses have been 
reported in SCZ postmortem studies 47,48, and the decrease in the number of inhibitory 
synapses in developmental SCZ cINs is in line with that observation. However, we do not 
see fewer excitatory synapses in developmental cINs transplanted into the mouse cortex but 
only in postmortem cINs. This can be explained if the decrease seen in human postmortem 
brains is due to the reduction in excitatory output from glutamatergic neurons rather than the 
intrinsic deficit of interneurons in receiving excitatory input. In addition, whereas numerous 
postmortem studies confirmed reduced GAD expression in SCZ interneurons, we did not see 
such defects in these developmental cIN populations. This discrepancy could be a 
consequence of comparing cells in culture with cells in vivo, or may have resulted from 
differences in interneuron age or subtypes. Also, it could be due to the fact that GAD 
expression is regulated in an activity-dependent manner 49. Thus, rather than being an 
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intrinsic deficit of SCZ interneurons, the reduction in GAD expression could have appeared 
only in the circuit environment with defective SCZ glutamatergic neurons.
In summary, the discovery of disrupted gene expression within SCZ risk loci, along with the 
animal and cell model effects, suggests the possibility of a causal relationship between 
protocadherins and SCZ. In addition, our study demonstrates the power of homogenous and 
functional populations of a specific neuronal subtype known to be affected in SCZ for 
probing the pathogenesis of schizophrenia, which may provide a pathway to identify more 
effective therapies and preventive interventions.
Methods
Generation of induced pluripotent stem cells
These study protocols were approved by the McLean Hospital/Partners Healthcare 
Institutional Review Board and New York Medical College Institutional Review Board. All 
procedures were performed in accordance with the Institutional Review Board’s guidelines 
and all human samples were obtained with informed consents. We have complied with all 
relevant ethical regulations. Human fibroblasts were obtained from the laboratories of Dr. 
Bruce Cohen (McLean Hospital), Dr. Daniel Weinberger (Lieber Institute for Brain 
Development), and Dr. Judith Rapoport (National Institute of Mental Health). Skin biopsies 
were performed on HC and SCZ patients. The skin tissue was cut out under local anesthesia 
(2% lidocaine with or without epinephrine), washed with phosphate buffered saline (PBS) 3 
times and placed in 35mm culture dishes. One drop of DMEM with Glutamax with 10% 
fetal bovine serum (FBS), 2% L-Glutamine, 1% Penicillin/Streptomycin solution (PS), and 
1% Amphotericin and Gentamicin solution was added on each piece of skin and put in the 
incubator (37°C/5% CO2). The skin samples in the culture dishes were changed with fresh 
media every other day to induce fibroblast cell growth as described in 50.
Human fibroblasts were reprogrammed using modified RNA methods 16 by Cellular 
Reprogramming, Inc. (San Diego, CA). Each fibroblast line was plated to 6-well plates 
without feeders at three different plating densities and subjected to messenger RNA 
reprogramming. Nascent colonies were bulk-passaged from the most productive well to 
establish passage 1 (P1) iPSC cultures on rLaminin-521 (BioLamina, Sweden) in Nutristem 
XF media (Biological Industries, Israel) and expanded in the same culture system until at 
least passage 3 before being characterized by 4’−6-diamidino-2-phenylindole (DAPI)/
OCT4/TRA-1–60 immunostaining and frozen down for storage.
Differentiation of iPSCs into cINs
Thawed human iPSCs were maintained on Matrigel (BD, San Hose, CA) coated plates with 
Essential 8 (E8) media (Invitrogen, Carlsbad, CA). For differentiation, iPSCs were 
trypsinized and grown as floating spheres in low adherent flasks in KSR media (DMEM, 
15 % knockout serum replacement, 2 mM L-glutamine and 10 μM β-mercaptoethanol (all 
from Invitrogen)) from day 0 to day 14. For neuroectoderm induction, cells were treated 
with LDN193189 (100 nM, Stemgent, Cambridge, MA) from day 0 to day 14 and 
SB431542 (10 μM, Tocris Cookson, Ellisville, MO) from day 0 to day 7. For MGE 
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phenotype induction, media was supplemented with IWP2 (5 μM, EMD Millipore, Billerica, 
MA) from day 0 to day 7 and SAG (0.1 μM, EMD Millipore) from d0 to d21. From day 14, 
cells were grown in N2AA media (DMEM-F12 with N2-supplement (1:200, Invitrogen) and 
200 μM ascorbic acid (AA, Sigma, St. Louis, MO)). FGF8 (100 ng/ml, Peprotech, Rocky 
Hill, NJ) was added from day 14 to day 21 to induce MGE phenotype at the expense of the 
CGE phenotype 17. N2AA media was supplemented with 10 ng/ml glial cell derived 
neurotrophic factor (GDNF, Peprotech) and 10 ng/ml brain derived neurotrophic factor 
(BDNF, Peprotech) from day 21. At day 45 of differentiation, cIN spheres were trypsinized 
in the presence of 0.1M trehalose (Sigma) and then plated on polyornithine (PLO; 15 mg/ml; 
Sigma)- and fibronectin (FN; 1 mg/ml; Sigma)-coated plates in B27GB media (DMEM-F12 
media with B27 supplement (1:100, Invitrogen), 10 ng/ml GDNF and 10 ng/ml BDNF). Cell 
lines differentiated for each experiment are summarized in Supplementary Table 3.
siRNA transfection
At day 28 of differentiation, cIN spheres were trypsinized and then plated onto PLO/
fibronectin-coated plates in B27GB media. Two days after plating, cINs were transfected 
with negative control siRNA (Ribobio), PCDHA siRNA (siG180312020039, Ribobio), 
PCDHG siRNA (siB180425114250, Ribobio) and PCDHA/PCDHG siRNA (Ribobio) at a 
final concentration of 25 nM by using Lipofectamine® RNAiMAX Reagent (Life 
Technologies) according to the manufacturer’s protocol. 6–8 hours after siRNA transfection, 
the cells were infected with a LV-Ubic-GFP virus, followed by arborization analysis 7 days 
after transfection.
Differentiation of iPSCs into Glutamatergic neurons
Human iPSC cells were seeded at a density of 106 cells/well on Matrigel-coated 6-well 
plates with E8 media, 5 μM Rock inhibitor Y-27632 (Selleck Chemicals, Houston, TX), 
Lentivirus that inducibly express Ngn2 and constitutively express Puromycin resistance gene 
(packaged using pLV_TRET_hNgn2_UBC_Puro plasmid from Addgene, Plasmid #61474 
(Addgene, Cambridge, MA)), 2 μg/ml of Doxycycline and 2 μg/ml of polybrene. After 
overnight incubation (day 1), the media was replaced with N2AAGB media (DMEMF12 
with N2 supplement (1:200), 200 μM ascorbic acid, 10 ng/ml GDNF and10 ng/ml BDNF) 
with 2 μg/ml of Doxycycline. At day 2, 1 μg/ml of Puromycin was added to the culture. At 
day 3, the media was changed with B27AAGB media (DMEMF12 with B27 Supplement 
(1:100), 200 μM ascorbic acid, 10 ng/ml GDNF and 10 ng/ml BDNF) and 2 μg/ml of 
Doxycycline and changed every other day until day 10. On days 11–14, the media was 
changed with B27AAGB media without doxycycline until the neurons were harvested for 
RNA preparation or fixed for immunocytochemistry on day 14 of differentiation.
Immunocytochemistry, Cell counting and Arborization analysis
Cells were fixed in 4% paraformaldehyde (PFA) for 10 min. The fixed cells were blocked in 
PBS with 10% normal serum and 0.1% Triton X-100 for 10 min at room temperature (RT). 
Cells were incubated with the primary antibody in PBS with 2% normal serum overnight at 
4°C. After washing in PBS, the cells were incubated with the fluorescently-labeled 
secondary antibody in PBS with 2% normal serum for 1 hr at RT. Cell nuclei were also 
counterstained with DAPI (Invitrogen, 1:10,000). The antibodies used are GAD1 (AB1511, 
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Millipore), Glutamate (G-6642, Sigma Aldrich), PV (PV 25, Swant and PA5–47693, 
ThermoFisher), PSD95 (3450P, Cell Signaling), Vglut1 (73–066, UC Davis), VGAT (131 
003, Synaptic Systems), Gephyrin (147 011, Synaptic Systems), SOX6 (AB5805, 
Millipore), b-Tubulin III (802001, Covance), OCT4 (CA0A3, Cell Signaling), Tra-160 
(ab16288, Abcam), GFP (ab13970, Abcam), NCAM (sc-106, Santa Cruz Biotech), MEF2C 
(5030S, Cell Signaling), SST (sc-7819, Santa Cruz Biotech), Human Cytoplasm (AB-121-
U-050, Stem Cells Inc.), VIP (20077, Immunostar), CCK (C2581, Sigma Aldrich), 
Calretinin (CG1, Swant), COUPTHII (PP-H7147–00, Perseus Proteomics), OLIG2 
(AB9610, Millipore), ChAT (AB114P, Chemicon), TH (P40101–150, Pel-Freez) and 5-HT 
(20080, Immunostar) and summarized in Supplementary Table 1. More information on 
antibody validation can be found in the Life Sciences Reporting Summary. After washing in 
PBS, coverslips were mounted onto slide glasses using Fluoromount-G (Southern Biotech, 
Birmingham, AL). Fluorescent images were taken using the EVOS FL Auto microscope 
(Life Technologies, Carlsbad, CA) or Olympus DSU Spinning Disc Confocal on an IX81 
inverted microscope (Olympus, Center Valley, PA).
For cell counting, Image J software (Version 1.51p, NIH, Bethesda, MD) was used to count 
the cell number using the multi point function. The experimenters were blind to the sample 
ID during data collection. Percentages of cells positive for each marker were quantified in 
relation to DAPI-stained nuclei from three independent differentiations, with a total of at 
least 500 cells counted for each line.
For arborization analysis, cells were infected with limiting concentration of LV-UbiC-GFP 
virus (MOI=0.001) to induce rare infections and fixed 10 days after infection for analysis. 
To test the effect of PKC inhibitor on arborization, cell cultures were treated with 5 μM of 
GO6893 or DMSO as a vehicle for 12 days before fixation. GFP+ cells were traced using 
ImageJ software version 1.51 (NIH) with the NeuronJ plug in to obtain parameters of 
arborization such as neurite length, neurite number from soma, and branch number. The 
experimenters were blind to the sample ID during data collection.
RNA preparation and Real time PCR
RNA samples were isolated using a TRIzol-reagent (Invitrogen) and 300ng of the total RNA 
was used for cDNA synthesis using the Oligo(dT)12–18 primer (Gene Link, Hawthorne, NY), 
Recombinant RNAse Inhibitor (Takara, Japan), 0.5 mM dNTP mix (Thermo Scientific, 
Waltham, MA), 5 mM DTT (Invitrogen), RevertAid H minus RT (Thermo Scientific), and 
5X Reaction Buffer (Thermo Scientific) in SimpliAmp™ Thermal Cycler (Applied 
Biosystems, Waltham, MA). The primer sequences used for real time PCR are summarized 
in Supplementary Table 2. The real time PCRs were performed using the CFX Connect™ 
Real-Time PCR Detection System (BioRad, Hercules, CA), with 40 cycles of denaturation 
(95°C for 15sec), annealing (55°C for 30sec), and extension (72°C for 30sec).
Whole-cell patch-clamp recordings in brain slices
For electrophysiological studies, human cINs derived from human iPSCs were infected with 
LV-Syn-ChR2 (H134R)-GFP and were transplanted as described below. Seven months after 
transplantation, acute brain slices containing the cerebral cortex were prepared using a 
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vibrating microtome (Leica Biosystems, Germany) for electrophysiological analysis. After 
recovery, brain slices were placed in the recording chamber and continuously perfused at the 
rate of 1 mL per minute with artificial cerebrospinal fluid containing 130 mM NaCl, 2.5 mM 
KCl, 2.5 mM CaCl2, 1 mM MgSO4, 1.25 mM NaH2PO4, 26 mM NaHCO3, and 10 mM 
glucose with 95 % O2 and 5 % CO2. Whole-cell patch-clamp recordings were performed at 
30–32°C using a Multiclamp 700B amplifier, a Digidata 1550A or 1320A digitizer and 
Clampex 10 software (Molecular Devices, Sunnyvale, CA). For recording grafted 
interneurons (GFP+ cells), the patch electrodes (~5 MOhm resistance) were filled with 
solution containing 150 mM K-gluconate, 5 mM NaCl, 1 mM MgCl2, 10 mM HEPES, 0.2 
EGTA, 2 mM MgATP, 0.5 mM NaGTP, and 5 mM biocytin (290 mOsm, adjusted to pH 7.3 
with KOH). For recording GFP– host cortical neurons, the patch electrodes were filled with 
solution containing 140 mM Cs-methanesulfonate, 5 mM NaCl, 1 mM MgCl2, 10 mM 
HEPES, 0.2 EGTA, 2 mM MgATP, 0.5 mM NaGTP, 5 mM QX 314 chloride, and 5 mM 
biocytin (290 mOsm, adjusted to pH 7.3 with CsOH). The liquid junction potential of 15.5 
and 8.9 mV was corrected for the K-gluconate-based and Cs-based pipette solutions, 
respectively. For experiments described in Figure 2c, whole-cell membrane capacitance 
(Cm) was compensated with the amplifier. Series (access) resistance was not compensated.
To calculate membrane resistance (Rm) and membrane capacitance (Cm) of grafted human 
interneurons in Supplementary Fig. 3b–c, we applied hyperpolarizing voltage pulses (–5 
mV) from the holding voltage of –85 mV and recorded currents in voltage-clamp mode with 
a sampling rate of 100 kHz in GFP+ grafted cells. The peak amplitude of the transient 
capacitive current (Ipeak) was used to estimate apparent access resistance (Ra) using the 
equation, Ra = –5 mV / Ipeak. Steady-state current (Iss) is the average current from the 
baseline for the last 5 ms of voltage pulse and was used to calculate membrane resistance 
(Rm) using the equation, Rm = (–5 mV / Iss) – Ra. Transient capacitive current was fitted 
with a double exponential function, I(t) = If exp(–t/τf) + Is exp(–t/τs), where If/τf and Is/τs 
are the fast and slow components of peak amplitudes and the decay time constants for the 
transient capacitive current. The weighted mean decay time constant (τw) was calculated 
from the equation, τw = τf [If/(If + Is)] + τs [Is/(If + Is)] and was then used to calculate 
membrane capacitance (Cm) from the equation, Cm = τw × (Ra + Rm) / (Ra × Rm).
To compare membrane excitability of grafted human cINs between groups (Figure 2d-e), the 
membrane potential was held at approximate –85 mV in current-clamp mode, and square 
pulses of depolarizing currents (10–90 pA with the increment of 10 pA, 0.5 s duration) were 
applied. The number of AP firings were counted for each current pulse in each grafted cell. 
The first AP induced by depolarizing current injection near threshold was used to calculate 
afterhyperpolarization (AHP), AP threshold, and AP half-width in Supplementary Fig. 3f–h. 
Spontaneous AP (sAP) firings were recorded in grafted interneurons in current-clamp mode 
without current injection or withdrawal for 2 minutes, and the average frequency of sAP 
firings was calculated for each grafted neuron (Figure 2f and Supplementary Fig. 3k). The 
resting membrane potential was estimated as the average membrane potential when the 
recorded graft cell did not fire APs spontaneously (Supplementary Fig. 3i).
Spontaneous EPSCs (sEPSC) were recorded in grafted human interneurons at −85 mV in 
voltage-clamp mode for 3–5 minutes (Figure 2g). The amplitude and frequency of sEPSC 
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were analyzed using the event detection function of the Clampfit software (Molecular 
Devices). The average amplitudes and frequencies of sEPSC were calculated for each 
grafted neuron and were compared between groups in Supplementary Fig. 5a–c. A blue 
collimated light-emitting diode (LED) with a 470 nm peak wavelength (M470L2, Thorlabs) 
was used for photostimulations of grafted interneurons expressing ChR2-GFP in Figure 2h-l 
and Supplementary Fig. 5d. Brain slices in the recording chamber were illuminated through 
a 40× water-immersion objective lens (Olympus LUMPLFLN 40XW or Leica HCX APO 
L40x #506155) and a 450–490 nm filter (Chroma). The illumination area was 0.17 mm2 and 
was centered at the cell patched for recording.
After electrophysiological recordings, brain slices were fixed in 4 % paraformaldehyde at 
4°C overnight. Recorded cells loaded with biocytin were labeled with streptavidin, Alexa 
568 conjugate (20 µg/mL in PBS, Thermo Fisher Scientific) as described previously 51. 
Images of biocytin/streptavidin-labelled cells were taken with the z-stack function using 
Leica a SP5 confocal microscope. Reagents were purchased from Tocris Bioscience (QX 
314 chloride, biocytin, and NBQX) or Sigma-Aldrich (ATP, GTP, and SR95531). Offline 
analysis of electrophysiological data was performed using the Clampfit 9 program 
(Molecular Devices).
Electrophysiological analysis of iPSC-derived cINs in vitro
After 4 months’ differentiation, human cINs were used for electrophygiological 
experiments. The cINs were transferred into a chamber continuously perfused (1.5–2 ml/
min) with extracellular bath solution containing 140 mM NaCl, 2.8 mM KCl, 1.3 mM 
NaHPO4, 10 mM dextrose, 1 mM MgCl2, 2 mM CaCl2, and 10 mM HEPES at pH 7.4 with 
osmolarity of 295–300mM. Recording pipettes with resistances of 4–6 MΩ were filled with 
an internal solution containing 120 mM K-gluconate, 9 mM KCl, 10 mM KOH, 8 mM 
NaCl, 10 mM HEPES, 3.48 mM MgATP, 0.4 mM Na3GTP, 17.5 mM sucrose, and 0.5 mM 
EGTA, with an osmolarity of ~290 and pH 7.3. Whole-cell patch clamp recordings were 
performed at RT using a multiclamp 700B, digidata 1550, and Clampex 10 software 
(Molecular Devices). Sampling was done at 5 kHz. Liquid junction potential of 12.9 mV 
was corrected for the internal solution used. Resting membrane potential was recorded at I = 
0. To compare membrane excitability, membrane potential was held at approximately –70 
mV and square pulses of depolarizing current steps were applied in current-clamp mode (–
10 – 80 pA in increments of 10 pA, 0.8s duration). The first AP induced by depolarizing 
current was used to analyze AP threshold, AHP, and AP half-width using Clampfit software 
(Molecular Devices). Averages ± SEM are represented in Supplementary Fig. 4. For the 
representative voltage clamp trace, cells were held at –70 mV and 800 ms duration square 
voltage pulses from –80 mV to –10 mV with increments of 10 mV were injected.
RNA-seq Analysis
For the pilot RNA-seq using 4 HC and 4 SCZ cINs, RNA quality was examined by the 
TapeStation 4200 (Agilent Technologies, Santa Clara, CA) and RNA concentration was 
determined using a Nanodrop (Thermo Fisher, Waltham, MA). Stranded cDNA libraries 
were prepared using TruSeq Stranded HT mRNA kits (Illumina, San Diego, CA) and 
sequenced on a NextSeq 500 (Illumina) in 75 bp paired-end mode. FASTQ files were 
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aligned to the human genome (assembly hg19) using STAR and GENCODE v19 
transcriptome annotation. Read pairs aligned to gene features were counted and summarized 
as RPKM values at the gene-level using featureCount, taking into account the strandness of 
the reads and all transcript variants of each gene in the GENCODE annotation. Differentially 
expressed genes were determined using the voom-limma package in the Bioconductor R 
software.
RNA-seq data of six samples from postmortem tissues were obtained from GEO (accession 
number of GSE87194), including 3 HC (SRR4289084, SRR4289085, and SRR4289086) 
and 3 SCZ (SRR4289106, SRR4289107, and SRR4289109). QuickRNASeq pipeline 52 was 
used for pairwise correlation comparison.
For the RNA-seq of 14 HC and 14 SCZ cINs, RNA quality was examined by the 
Bioanalyzer 2100 (Agilent Technologies) and RNA concentration was determined by the 
Qubit Fluorometric Quantitation (Life Technologies). For each sample, 200–300ng of RNA 
was used to construct a cDNA sequencing library using the TruSeq Stranded mRNA Library 
Preparation Kit (Illumina), in accordance with the manufacturer’s protocol using the poly-
adenylated RNA isolation. Sequencing of paired-end reads (75 bp × 2) was performed in the 
Illumina NextSeq 550 system. Raw sequence reads were de-multiplexed and trimmed for 
adapters by using the Illumina bcl2fastq conversion software (v2.19). Sequence reads of 
each sample were pseudo-aligned to human hg38 reference transcriptome and the gene 
transcript abundance was quantified by using Kallisto. The differential expression of genes 
and transcripts were achieved by using the Sleuth and DESeq2 R packages. The Kallisto-
Sleuth workflow and Kallisto-DESeq2 workflows are based upon a previous publication 53. 
The RNA-seq data were deposited at the GEO < https://www.ncbi.nlm.nih.gov/geo/w> and 
the accession number is GSE118313 and GSE121376.
Genotype analysis
Samples from Dr. Cohen’s laboratory were genotyped at the Broad Institute using the 
Illumina HumanOmniExpress-12v1 or the PsychChip 15048346 B manifest. QC was 
performed using PLINK 1.9 to retain variants with missingness <2% and exclude single 
nucleotide polymorphisms (SNPs) with excess heterozygosity (HardyWeinberg equilibrium 
χ2 P-values <10−6). Genotype imputation was performed using a stepwise pre-phasing/
imputation approach implemented by Eagle v2.3 and Minimac3. The 1000 Genomes Phase 
3 data was used as a reference.
Samples from Dr. Weinberger’s laboratory were genotyped at Lieber Institute for Brain 
Development. SNP genotyping with HumanHap650Y_V3 (N=135), Human 1M-Duo_V3 
(N=357) and Omni5 (N=3) BeadChips (Illumina) was carried out according to the 
manufacturer’s instructions with DNA extracted from cerebellar tissue. The genotype data 
were processed and normalized with the crlmm R/Bioconductor package 54 separately by 
platform. Genotype imputation was performed on high-quality observed genotypes 
(removing low quality and rare variants) using the prephasing/imputation stepwise approach 
implemented in IMPUTE2 55 and Shape-IT 56, with the imputation reference set from the 
full 1000 Human Genomes Project Phase 3 data set, separately by platform. We retained 
common SNPs (MAF > 5%) that were present in the majority of the samples (missingness < 
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10%) that were in Hardy Weinberg equilibrium (at p >1×10−6) using the Plink 57 version 1.9 
tool kit [`plink --bfile $BFILE --geno 0.1 --maf 0.05 --hwe 0.000001`]. We then identified 
linkage disequilibrium (LD)-independent SNPs.
Transplantation of human cINs, Immunohistochemistry, and Synapse analysis
All animal protocols were approved by the Institutional Animal Care and Use Committee at 
McLean Hospital, New York Medical College, and University of California Riverside. 
Procedures were carried out in accordance with the approved guidelines. We have complied 
with all relevant ethical regulations. The cIN spheres were trypsinized on day 45 of 
differentiation, infected with LV-Syn-ChR2 (H134R)-GFP to facilitate optogenetic study and 
then treated with CultureOne (Invitrogen, 1:100) for a week. Eight weeks after 
differentiation, cells were trypsinized and resuspended in Transplantation media (HBSS, 4.5 
mg/ml of sucrose, 0.1 ng/ml GDNF, 0.1 ng/ml BDNF, 0.02 μM Boc-Asp(OMe)-
fluoromethyl ketone) at a concentration of 105 cells/μl and used for transplantation into the 
cortices of 5–7 weeks old male and female Nod Scid mice (Charles River Laboratory, 
Kingston, NY) under pentobarbital anesthesia (66mg/kg) using a Kopf stereotaxic 
instrument (Kopf, Tujunga, CA), equipped with a mouse adapter (Stoelting, Wood Dale, IL). 
A 1 μl volume of cells were injected at each of the following coordinates: AP −1.75 mm, L 
±2.2 mm, V −2.0 mm; AP 0 mm, L ±3.8 mm, V −2.0 mm; AP +2.12 mm, L ±4.2 mm, V 
−1.8mm. Four months after transplantation, the mice were perfused with 0.1 M PBS 
followed by 4% paraformaldehyde (PFA). The brains were removed, and post-fixed in 4 % 
PFA solutions overnight and then placed in 30% sucrose solutions for 2 days. Forty-
micrometer-thick coronal sections were cut on a freezing microtome (American Optical 
Corp., Buffalo, NY). The brain sections were blocked in PBS with 10% normal serum and 
0.1% Triton X-100 for 10 min at RT and then incubated with primary antibody in PBS with 
2% normal serum overnight at 4°C. After washing with PBS, the sections were incubated 
with the secondary antibody in PBS with 2% normal serum for 1 hour at RT. The antibodies 
used are summarized in Supplementary Table 1. Sections were visualized by the Confocal 
Leica TCS SP8 (Leica Microsystems, Buffalo Grove, IL) using sequential acquisition of 
separate channels with the 100X objective.
For synapse analysis, images were processed using Imaris software 9.2 (Bitplane, 
Switzerland), which allows objective counting of synaptic puncta based upon absolute 
fluorescent intensity. Synaptic puncta positive for VGAT (inhibitory presynaptic), Gephyrin 
(inhibitory postsynaptic), Vglut1 (excitatory presynaptic), PSD95 (excitatory postsynaptic) 
were identified with spot diameters of 0.5 μm. For inhibitory synapse analysis, only 
presynaptic VGAT+ puncta that overlapped with GFP on confocal single plane images were 
included in the analysis, excluding all other VGAT+ puncta. For postsynaptic excitatory 
puncta on cINs, only postsynaptic PSD95+ puncta overlapped with GFP on confocal single 
plane images were included in the analysis. Synapse formation was determined by 
juxtaposition of GFP+VGAT+ puncta and Gephyrin+ puncta for inhibitory synapses and GFP
+PSD95+ puncta and Vglut1+ puncta for excitatory synapses. The data were expressed as 
synapse numbers per GFP+ neuronal surface area. For inhibitory synapse analysis, we 
analyzed a total of 835 neurite segments with a total area of 9,622 µm2 for HC cINs and a 
total of 1,168 neurite segments with a total area of 13,611 µm2 for SCZ cINs. Total counted 
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colocalized puncta numbers were 1,286 for HC cINs and 1,104 for SCZ cINs. For excitatory 
synapse analysis, we analyzed a total of 614 neurite segments with a total area of 11,732 
µm2 for HC cINs and a total of 669 neurite segments with a total area of 11,413 µm2 for 
SCZ cINs. Total counted colocalized puncta numbers were 3,542 for HC cINs and 4,410 for 
SCZ cINs. The experimenters were blind to the sample ID during data collection.
iDISCO+ tissue-clearing and 3D imaging
To visualize the cIN grafts in 3D in mouse brains, we performed immunohistochemistry/
tissue-clearing according to the iDISCO+ tissue clearing method 27. The mouse was 
perfused with 0.1 M PBS followed by 4% PFA 4 months after transplantation. The brain was 
harvested and post-fixed in 4 % PFA solutions overnight. The mouse brain was dehydrated, 
bleached, rehydrated, and blocked as described 27. The following antibodies were used for 
staining: mouse-anti-human cytoplasm (1:1,000, StemCells Inc. Newark, CA), and Alexa 
Fluor 568-conjugated donkey anti-mouse (1:1,000, Thermo Scientific). Solvent-cleared 
brain was imaged in its entirety with light-sheet microscopy (LaVision Ultramicroscope II 
Light Sheet, LaVision BioTec, Germany) at 2.5 X objective. Z-stack images taken from 
light-sheet microscopy were subjected to 3D rendering and spot analysis using Imaris 
software 9.2 (Bitplane).
Histological analysis of WT and Pcdha Δα/Δα mice
WT and Pcdha Δα/Δα mice were generated as described 58 and the mice were perfused at 
P40 for histological analysis. The mouse brains were post-fixed using a 4% PFA solution 
overnight and then placed in a 30% sucrose solution for 2 days. Forty-micrometer-thick 
coronal sections were cut by a microtome. Brain sections were blocked/permeabilized in 
PBS with 10% normal serum and 0.1% Triton X-100 for 10 min at RT and then incubated 
with an antibody against PV raised in rabbits (Swant, Bellinzona, Switzerland) in PBS with 
2% normal serum overnight at 4°C. For amplification of signals, the sections were incubated 
with the biotinylated anti-rabbit antibody for 2 hours at RT, then followed by amplification 
steps as follows; Alexa568-streptavidin (1: 2,000, Life Technologies) for 2 hours at RT, then 
biotinylated anti-streptavidin antibody (1: 2,000, Vector) for 2 hours at RT and then 
incubated Alexa568- streptavidin for 2 hours at RT. Z-stack images were obtained using an 
Olympus DSU Spinning Disc Confocal on an IX81 inverted microscope. Arborization of 
WT vs Pcdha Δα/Δα PV+ cINs was analyzed using Neuron J to obtain parameters such as 
neurite length, neurite number from the soma, and branch number within 150 μm from the 
cell body. The experimenters were blind to the sample ID during data collection.
The synapse analysis was performed using triple-stained WT or KO mice brain sections 
(PV/Gephyrin/VGAT or PV/VGlut1/PSD95) as described above. For inhibitory synapse 
analysis, we analyzed a total of 5,497 neurite segments with a total area of 55,186 µm2 for 
WT cINs and a total of 4,733 neurite segments with a total area of 57,671 µm2 for Pcdha 
Δα/Δα
 mice cINs. Total counted colocalized puncta numbers were 20,393 for WT and 12,097 
for Pcdha Δα/Δα mice. For excitatory synapse analysis, we analyzed a total of 3,367 neurite 
segments with a total area of 30,394 µm2 for WT cINs and a total of 3,648 neurite segments 
with a total area of 44,121 µm2 for Pcdha Δα/Δα cINs. Total counted colocalized puncta 
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numbers were 9,655 for WT and 19,125 for Pcdha Δα/Δα mice. The experimenters were 
blind to the sample ID during data collection.
Prepulse inhibition (PPI) of Pcdha ΔCR/ΔCR or Pcdha ΔBneo/ΔBneo mice
All experiments were approved by the Institutional Animal Care and Use Committee at 
Osaka University. Procedures were carried out in accordance with the approved guidelines. 
We have complied with all relevant ethical regulations. We used 10–13 weeks old male 
Pcdha ΔCR/ΔCR mice and 10–13 weeks old male Pcdha ΔBneo/ΔBneo mice for behavior testing. 
The mice were maintained in groups of four per cage with a 12 h light/dark cycle and ad 
libitum access to food and water. Pcdha ΔCR/ΔCR mice and Pcdha ΔBneo/ΔBneo mice were 
established by backcrossing with C57BL/6 more than 8 times 24, and then used for PPI 
testing. A startle reflex measurement system was used (O’Hara &Co., Ltd). The background 
noise level was 70 dB in each chamber. Each mouse was placed in a Plexiglas tube for 5 min 
as an initial period of acclimation. The responses were recorded for 160 msec starting with 
the onset of the prepulse stimuli. The maximum startle amplitude scored during the 160 
msec was used. Mice received a series of six trial types, two types for startle trials and three 
types for prepulse inhibition trials. The startle stimulus was a 110- or 120-dB sound. The 
prepulse sound was a 74-, 78- or 82-dB sound, which presented 100 ms before startle 
stimulus. These six trial types were presented in pseudorandom order and 10–20 sec 
intertrial intervals. The following formula was used to calculate percentage prepulse 
inhibition of ASR: (startle response for pulse alone - startle response for pulse with pre-
pulse) / startle response for pulse alone) X 100.
Histological analysis of human postmortem tissue
Formalin-fixed PFC of human postmortem tissues from 8 HC and 8 SCZ were obtained 
from the McLean Hospital, the University of Maryland Brain and Tissue Bank, the 
University of Pittsburgh, and the Human Brain and Spinal Fluid Resource Center (Figure 
8a). The tissue samples were placed in a 30% sucrose solution for 2 days. Forty-micrometer-
thick coronal sections were cut using a cryostat (Leica). The brain sections were blocked in 
PBS with 10% normal serum and 0.1% Triton X-100 for 10 min at RT and then incubated 
with primary antibody in PBS with 2% normal serum overnight at 4°C. After washing with 
PBS, the sections were incubated with the secondary antibody in PBS with 2% normal 
serum for 1 hour at RT. The sections were incubated in a solution containing 0.01M CuSO4 
(Sigma) and 0.05 M Ammonium acetate (Sigma) for 2 min at RT and then washed with PBS 
5 times. For arborization analysis, Z-stack images of layer 3 PV+ neurons were taken using 
the EVOS FL Auto microscope (Life Technologies) and analyzed using Neuron J to obtain 
parameters such as neurite length, neurite number from the soma, and branch number within 
150 μm of the cell body. The experimenters were blind to the sample ID during data 
collection.
For synapse analysis, synaptic puncta images of layer 3 PV+ neurons were taken using a 
LSM 710 confocal microscope (Carl Zeiss, Germany) using sequential acquisition of 
separate channels with the 100X objective. For inhibitory synapse analysis, we analyzed a 
total of 7,471 neurite segments with a total area of 57,218 µm2 for HC postmortem tissue 
and a total of 7,644 neurite segments with a total area of 68,563 µm2 for SCZ postmortem 
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tissue. Total counted colocalized puncta numbers were 14,562 for HC postmortem tissue and 
13,113 for SCZ postmortem tissue. For excitatory synapse analysis, we analyzed a total of 
9,051 neurite segments with a total area of 111,301 µm2 for HC postmortem tissue and a 
total of 4,240 neurite segments with a total area of 31,165.3 µm2 for SCZ postmortem tissue. 
Total counted colocalized puncta numbers were 27,086 for HC postmortem tissue and 4,822 
for SCZ postmortem tissue. The experimenters were blind to the sample ID during data 
collection.
Statistical analysis
All statistical analyses were performed using GraphPad Prism7 (GraphPad Software, La 
Jolla, CA), SPSS (version 16; SPSS Inc., Chicago, IL) and SAS statistical software (9.4, 
SAS Institute, Cary, NC). We tested normality of data distribution as summarized in 
Supplementary Tables 15–18. For cell counting analysis (Figure 1 and Supplementary Fig. 
1), one-way ANOVA was used to analyze the differences among group means of individual 
cell lines. For in vitro electrophysiology data (Supplementary Fig. 4), Welch’s t-test was 
used to compare the mean difference between groups. For mice behavioral assessments 
(Figure 5d-e), the data were analyzed by the two-tailed unpaired t-test. For real time PCR 
analysis of siRNA-mediated gene KD (Supplementary Fig. 10c), the data were analyzed by 
two-tailed unpaired t-test.
For phenotype analysis such as in vivo electrophysiology data (Figure 2, Supplementary Fig. 
3 and 5, and Supplementary Table 15), gene expression analysis (Figure 3–4, Supplementary 
Fig. 8, and Supplementary Table 16), synapse analysis (Figure 5b–c, Figure 7f-g, Figure 8c-
d, and Supplementary Table 17) and arborization analysis (Figure 5a, Figure 6a, Figure 8b, 
and Supplementary Table 17), the linear mixed effect model with random intercept was used 
for the continuous data and the mixed effects log-linear model with random intercept was 
used for count data to compare the mean difference between groups 59,60. Mixed model 
methods were chosen to handle clustering and covariance among correlated samples. Some 
of the data were log-transformed to deal with skewedness as indicated in Supplementary 
table 15–18. Power analysis (Figure 2l) was performed using the tests for two means in a 
cluster design to incorporate the clustering of samples within the same lines. For 
arborization analysis after GO6893 treatment (Figure 6b and Supplementary Table 17), the 
two-level hierarchical mixed effects models were used by incorporating the two random 
effects (i.e., the second effect is for observations with and without GO6893 nested within the 
first effect, same batch of cells) to account for correlation among the paired samples in each 
cell line. For arborization analysis after siRNA transfection (Figure 6c and Supplementary 
Table 18), the two-level hierarchical linear mixed effect model for the continuous data and 
the two-level hierarchical mixed effect log-linear model for the count data were used. 
Dunnett’s test was used to compare each of groups with a negative control siRNA control 
group as a post hoc analysis with an adjustment for multiple comparisons. A two-sided 
significance level of 5% was used for all analyses. More information on statistical analysis 
can be found in the Life Sciences Reporting Summary.
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Study design
No statistical method was used to pre-determine sample sizes. However, the sample size we 
used in this study is similar to the largest one among previous publications 61. This sample 
size was adequate in identifying the disruption of protocadherin expression in SCZ cINs. No 
data was excluded from analysis. Experimental cohorts were chosen based on our selection 
criteria (Caucasian male patients treated with Clozapine vs. age- and gender-matched 
Caucasian male healthy controls) without randomization to reduce variation caused by age, 
ethnicity and gender. Blinding was used during cell counting, arborization analysis and 
synapse analysis.
Life Sciences Reporting Summary
Further information on experimental design is available in the Life Sciences Reporting 
Summary.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. SCZ and HC iPSCs efficiently generate homogeneous population of cINs.
The lines used in each experiment are summarized in Supplementary Table 3.
(a) Table of subjects analyzed in pilot study.
(b) Immunocytochemistry analysis of human PSC markers, Oct4 and Tra-1–60, in generated 
iPSCs (Scale bar = 200 μm). Differentiation was repeated at least 3 times with comparable 
results.
(c) Differentiation scheme of cINs from human iPSCs. SRM: serum replacement media, 
LDN: 100 nM LDN193189, SB: 10 μM SB431542, SAG: 0.1 μM Smoothened agonist, and 
IWP2: 5 μM Inhibitor of Wnt production-2.
(d) Immunocytochemistry analysis for expression of β-Tubulin III, Sox6, and GAD1 in 
generated cINs after 8 weeks’ differentiation (Scale bar = 50 μm). Differentiation was 
repeated at least 3 times with comparable results.
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(e) Cell counting analysis after 8 weeks’ differentiation. Data are presented as mean ±SEM 
from three independent differentiations (n = 3 differentiations). There were no significant 
differences among different lines based on one-way ANOVA (β-Tubulin III p = 0.2626, 
Sox6 p = 0.3802, and GAD1 p = 0.5072).
(f) Real-time PCR analysis of different cell types (H9 hESC: n = 3 batches, hiPSC: n = 6 
batches from 2 iPSC lines, HC cIN: n = 9 batches from 3 lines, SCZ cIN: n = 9 batches from 
3 lines, and glutamatergic neuron: n = 6 batches from 2 lines). Results were normalized 
using Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) expression levels and 
presented as mean ±SEM.
See also Supplementary Fig. 1–2.
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Figure 2. Neuronal and synaptic properties of cINs transplanted into mouse cerebral cortex.
The lines used in each experiment are summarized in supplementary Table 3.
(a) Transplantation scheme of cINs into Nod Scid mice. Eight-week old cINs infected with 
LV-Syn-ChR2-GFP were transplanted into cerebral cortices. Brain slices were prepared for 
electrophysiological experiments 7 months after grafting.
(b) Left: image showing ChR2-GFP-expressing grafted cINs (green) in the cerebral cortex. 
Right: patch-clamp recordings were performed with grafted cells, which generated ChR2-
mediated photocurrents and were labeled with biocytin-streptavidin-Alexa 568 (scale bar = 
10 µm).
(c) Voltage pulses from –115 mV to 85 mV with 20 mV increments induced transient inward 
(Na+) and sustained outward currents (K+) in a grafted cINs. Na+ currents were quantified as 
peak inward currents induced by depolarization to –35 mV (red). K+ currents were 
quantified as sustained outward currents induced by depolarization to 85 mV (blue).
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(d) AP firing induced by current injection in a grafted cell at approximately –85 mV.
(e) Summary plot of AP firings in transplanted cINs in the HC (15 cells) and SCZ groups 
(16 cells). Repeated measures two-way ANOVA was used for analysis (Main effect of 
groups, p = 0.77; group × current interaction, p = 1.00). Error bars are the SEM.
(f) Left: spontaneous AP firings recorded at RMP in a grafted cIN. Right: average AP 
firings.
(g) Spontaneous EPSCs recorded in a grafted cell at –85 mV (left) and blocked by NBQX 
(right).
(h) Photostimulation activates ChR2-expressing grafted cINs, generating IPSCs in GFP– 
host neurons labeled with biocytin (red, scale bar = 10 µm).
(i) Image showing a GFP+ grafted human cIN (green) and a GFP– host cortical neuron 
labeled with biocytin (red).
(j) Photostimulation induced IPSCs recorded at 0 mV in a host neuron (black) and inhibited 
by SR95531 (10 mM, blue).
(k) IPSCs induced by photostimulations (40 mW/mm2) and recorded in host neurons in the 
HC (black) and SCZ groups (red).
(l) Left: comparison of the proportion of host cells with IPSCs in the HC (15 cells out of 21 
cells examined) and SCZ groups (13 cells our of 20 cells examined; p = 0.66, χ2 test). 
Right: comparison of IPSC amplitude in the HC (15 cells) and SCZ groups (13 cells; p = 
0.37). Error bars are the SEM.
See also Supplementary Fig. 3–5. For detailed statistics information, see Supplementary 
Table 15.
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Figure 3. PCDHA2 expression is significantly altered in developing SCZ cINs.
The lines used in each experiment are summarized in Supplementary Table 3. The 
breakdown data are summarized in Supplementary Table 4–5.
(a) RNA-seq transcriptome profiling of cINs derived from 4 HC vs. 4 SCZ iPSCs in three 
independent differentiations (n = 12 differentiations). Gene expression is shown as reads per 
kilobase of transcript per million mapped reads (RPKM). Differential expression was 
analyzed in R by the Voom function in Limma with adjusted multiple testing. Center and 
error bars show mean ± SEM.
(b) PCDHA2 expression is significantly decreased in SCZ cINs. Data were collected by 
RNA-seq transcriptome profiling of cINs derived from 4 HC vs. 4 SCZ iPSCs in three 
independent differentiations (n = 12 differentiations). Differential expression was analyzed 
in R by the Voom function in Limma with adjusted multiple testing. Center and error bars 
show mean ± SEM.
(c) Quantitative real-time PCR analysis of PCDHA2 expression in cINs derived from 4 HC 
iPSCs vs. 4 SCZ iPSCs in three independent differentiations (n = 12 differentiations). Data 
were normalized by GAPDH expression level. Center and error bars show mean ± SEM.
(d) The differentiation scheme for glutamatergic neurons. Human iPSCs were plated with 
Lentivirus expressing inducible Ngn2-puroR and treated with Doxycycline (DOX) until day 
10. Cells were treated with Puromycin on day 2 and were used for analysis on day 14.
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(e) Immunocytochemistry analysis of iPSC-derived glutamatergic neurons (scale bar = 20 
μm). This analysis was repeated in 2 batches of differentiation with similar results.
(f) Quantitative real-time PCR analysis of PCDHA2 expression in glutamatergic neurons 
derived from 4 HC vs. 4 SCZ iPSCs in two independent differentiations (n = 8 
differentiations). PCDHA2 expression level was normalized using that of GAPDH. Center 
and error bars show mean ± SEM.
See also Supplementary Fig. 6–7. For detailed statistics information, see Supplementary 
Table 15.
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Figure 4. Multiple PCDHA family members are affected in developing SCZ cINs.
The lines used in each experiment are summarized in Supplementary Table 3. The 
breakdown data are summarized in Supplementary Table 6.
(a) Table of subjects in the expanded cohort.
(b) Changes in multiple PCDHA gene expression, analyzed by RNA-seq of cINs derived 
from 14 HC vs. 14 SCZ iPSCs in two independent differentiations (n = 28 differentiations). 
Expression level was shown as transcripts per kilobase million (TPM). Differentially 
expressed genes were analyzed by DESeq2 and Sleuth (Wald test for significance testing). 
Center and error bars show mean ± SEM.
(c) Quantitative real-time PCR analysis of expression of multiple PCDHA family members 
in cINs derived from 14 HC vs. 14 SCZ iPSCs in two independent differentiations (n = 28 
differentiations). The expression levels of each gene were normalized by that of the GAPDH 
gene. Center and error bars show mean ± SEM.
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(d) Correlation between genotype and gene expression level. R designates reference allele 
(G) and A designates alternate allele (A) of rs7445192. Gene expression levels were 
normalized by β-actin and grouped by genotype. The difference between the RR group and 
the AA group was analyzed by the two-tailed unpaired t-test (n = 6 for RR and n = 8 for AA; 
PCDHA2 p = 0.5102, PCDHA3 p = 0.4551, PCDHA6 p = 0.7251 and PCDHA8 p = 
0.3548). Center and error bars show mean ± SEM.
(e) Heat map depicting expression changes of protocadherin genes in SCZ cINs. Blue color 
depicts downregulation in SCZ cINs and red depicts upregulation. Numbers in colored box 
indicate expression change in log2 fold change.
(f) eQTL diagram of different protocadherin genes, showing the presence of multiple eQTLs 
for protocadherin family members within SCZ risk loci. Green bar designates SCZ risk loci 
(Chr5: 140,023,664–140,222,664). Red dots are significant cis-eQTLs for the given gene at 
FDR<5%. More detailed information on this analysis can be found in the Commonmind 
portal (https://www.synapse.org/#!Synapse:syn2759792/wiki/69613).
See also Supplementary Fig. 8. For detailed statistics information, see Supplementary Table 
16.
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Figure 5. Pcdha KO (Pcdha Δα/Δα) leads to cIN abnormalities in the PFC and behavioral 
abnormalities.
The breakdown data for each mouse are summarized in Supplementary Table 7–8.
(a) Arborization analysis of PV+ cINs in PFC of littermate wildtype (WT) or Pcdha KO 
(Pcdha Δα/Δα) mice. Arborization within 150 µm of the cell body was traced and analyzed 
using ImageJ with the Neuron J plugin and is presented as mean ±SEM (n = 100 neurons per 
group).
(b-c) Analyses of inhibitory and excitatory synapses in PFC of WT and Pcdha Δα/Δα mice 
using Imaris software. For inhibitory synapse analysis on PV+ cINs, the data are presented 
as the number of inhibitory synapses (juxtaposed PV+VGAT+ puncta and Gephyrin+ puncta) 
per 100 µm2 of PV+ cINs. For excitatory synapse analysis on PV+ cINs, the data are 
presented as the number of excitatory synapses (juxtaposed PV+PSD95+ puncta and Vglut1+ 
puncta) per 100 µm2 of PV+ cINs. Data are presented as mean ±SEM (n = 25 116 µm × 116 
µm images per group).
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(d) Pcdha ΔCR/ΔCR mice show a deficit in PPI. Amplitudes of startle response and percentage 
of PPI are shown. The data were analyzed using the two-tailed unpaired t-test. Data are 
shown as mean ±SEM (WT: n = 17 mice, ΔCR: n = 18 mice).
(e) Pcdha ΔBneo/ΔBneo mice show a deficit in PPI. Amplitudes of the startle response and the 
percentage of PPI are shown. The data were analyzed using the two-tailed unpaired t-test. 
Data are shown as mean ±SEM for the indicated numbers of mice (n = 13 mice for each 
group).
See also Supplementary Fig. 9. For detailed statistics information, see Supplementary Table 
17.
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Figure 6. Developing SCZ cINs show arborization deficit relevant to protocadherin dysregulation 
in vitro.
The lines used in each experiment are summarized in Supplementary Table 3. The 
breakdown data for each line are summarized in Supplementary Tables 9–11.
(a) Arborization analysis of HC vs. SCZ cINs infected with a limiting titer of GFP-
expressing lentivirus. Images were analyzed using ImageJ with the Neuron J plugin. (n = 
180 neurons). Center and error bars show mean ± SEM.
(b) Arborization analysis of PKC inhibitor-treated HC vs. SCZ cINs. cINs infected with a 
limiting titer of GFP-expressing lentivirus were treated with PKC inhibitor GO6893 for 12 
days and analyzed using ImageJ with the Neuron J plugin (n = 160 neurons). Center and 
error bars show mean ± SEM.
(c) Arborization analysis of siRNA transfected HC vs. SCZ cINs (two independent 
differentiations). cINs infected with a limiting titer of GFP-expressing lentivirus were 
transfected with siRNA against PCDHA, PCDHG, or a mixture (PCDHA+PCDHG) and 
analyzed using ImageJ with the Neuron J plugin (n=60 neurons). Center and error bars show 
mean ± SEM. The asterisk indicates p < 0.05 compared to the negative control.
See also Supplementary Fig. 10. For detailed statistics information, see Supplementary Table 
17–18.
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Figure 7. Developing SCZ cINs show synaptic deficit in vivo after transplantation into mice 
brains.
The lines used in each experiment are summarized in Supplementary Table 3. The 
breakdown data for each line are summarized in Supplementary Table 12.
(a) Schematic diagram of transplantation analysis of HC vs. SCZ cINs.
(b) 3D Lightsheet microscopy images of an iDISCO+-cleared mouse cortex transplanted 
with iPSC-derived human cINs, stained with human cytoplasm antibody. Major grid in 
reference frame is 300 µm. This result is from a single whole brain staining.
(c-d) Recognition of grafted neurons by Imaris software shown by green dots. Note that the 
cells in the front look bigger with bigger green dots and the cells in the back look smaller 
with smaller green dots. Graphs depict the location of grafted cells along the X, Y, Z axes 
and distance from the injection site. This result is from a single whole brain staining.
(e) Immunocytochemistry analysis of transplanted cINs 7 months after grafting (scale bar = 
50 µm). Left: MEF2C+ neurons among human NCAM+ grafted neurons (p = 0.7737, chi-
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square test). Right: SST+ neurons among human NCAM+ grafted neurons (p = 0.6575, chi-
square test). White arrowheads indicate double-positive neurons.
(f) Inhibitory synapse analysis on transplanted GFP+ cINs 4 months after grafting. The data 
are presented as the number of inhibitory synapses (juxtaposed GFP+VGAT+ puncta and 
Gephyrin+ puncta) per 100 µm2 of GFP+ cINs. Center and error bars show mean ± SEM (n = 
14 116 µm × 116 µm images per group).
(g) Excitatory synapse analysis on transplanted GFP+ cINs 4 months after grafting. The data 
are presented as the number of excitatory synapses (juxtaposed GFP+PSD95+ puncta and 
Vglut1+ puncta) per 100 µm2 of GFP+ cINs. Center and error bars show mean ± SEM (n = 
14 116 µm × 116 µm images per group).
See also Supplementary Fig. 11. For detailed statistics information, see Supplementary Table 
17.
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Figure 8. SCZ cINs in postmortem tissue show similar deficit as in developmental SCZ cINs.
The breakdown data for each line are summarized in Supplementary Table 13–14.
(a) Table of subjects used in the postmortem study.
(b) Arborization analysis of layer 3 PV+ cINs in HC and SCZ postmortem PFC. 
Arborization within 150 µm of the cell body was traced and analyzed using ImageJ with the 
Neuron J plugin. Data are presented as mean ±SEM (n = 160 neurons).
(c-d) Synapses analysis of layer 3 PV+ cINs in HC and SCZ postmortem PFC using Imaris 
software. For inhibitory synapse analysis on PV+ cINs, the data are presented as the number 
of inhibitory synapses (juxtaposed PV+VGAT+ puncta and Gephyrin+ puncta) per 100 µm2 
of PV+ cINs. For excitatory synapse analysis on PV+ cINs, the data are presented as the 
number of excitatory synapses (juxtaposed PV+PSD95+ puncta and Vglut1+ puncta) per 100 
µm2 of PV+ cINs. Data are presented as mean ±SEM (n = 32 116 µm × 116 µm images).
See also Supplementary Fig. 12. For detailed statistics information, see Supplementary Table 
17.
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